IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.9855
-0.0075 (-0.76%)
At close: Sep 12, 2025, 4:00 PM EDT
0.9901
+0.0046 (0.47%)
After-hours: Sep 12, 2025, 7:53 PM EDT

IceCure Medical Statistics

Total Valuation

IceCure Medical has a market cap or net worth of $77.51 million. The enterprise value is $74.50 million.

Market Cap77.51M
Enterprise Value 74.50M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

IceCure Medical has 78.65 million shares outstanding. The number of shares has increased by 19.84% in one year.

Current Share Class 78.65M
Shares Outstanding 78.65M
Shares Change (YoY) +19.84%
Shares Change (QoQ) +1.79%
Owned by Insiders (%) 35.44%
Owned by Institutions (%) 0.32%
Float 50.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 19.81
Forward PS 20.08
PB Ratio 20.01
P/TBV Ratio 26.81
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 26.73
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.82.

Current Ratio 1.18
Quick Ratio 0.72
Debt / Equity 0.82
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -230.80% and return on invested capital (ROIC) is -120.95%.

Return on Equity (ROE) -230.80%
Return on Assets (ROA) -76.40%
Return on Invested Capital (ROIC) -120.95%
Return on Capital Employed (ROCE) -537.63%
Revenue Per Employee $42,227
Profits Per Employee -$236,061
Employee Count66
Asset Turnover 0.21
Inventory Turnover 0.83

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +59.70% in the last 52 weeks. The beta is 2.48, so IceCure Medical's price volatility has been higher than the market average.

Beta (5Y) 2.48
52-Week Price Change +59.70%
50-Day Moving Average 0.98
200-Day Moving Average 1.10
Relative Strength Index (RSI) 49.14
Average Volume (20 Days) 1,921,153

Short Selling Information

The latest short interest is 1.15 million, so 1.47% of the outstanding shares have been sold short.

Short Interest 1.15M
Short Previous Month 756,095
Short % of Shares Out 1.47%
Short % of Float 2.27%
Short Ratio (days to cover) 0.67

Income Statement

In the last 12 months, IceCure Medical had revenue of $2.79 million and -$15.58 million in losses. Loss per share was -$0.28.

Revenue2.79M
Gross Profit 1.00M
Operating Income -15.86M
Pretax Income -14.49M
Net Income -15.58M
EBITDA -15.54M
EBIT -15.86M
Loss Per Share -$0.28
Full Income Statement

Balance Sheet

The company has $5.38 million in cash and $2.37 million in debt, giving a net cash position of $3.01 million or $0.04 per share.

Cash & Cash Equivalents 5.38M
Total Debt 2.37M
Net Cash 3.01M
Net Cash Per Share $0.04
Equity (Book Value) 2.89M
Book Value Per Share 0.05
Working Capital 1.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.20 million and capital expenditures -$65,000, giving a free cash flow of -$14.26 million.

Operating Cash Flow -14.20M
Capital Expenditures -65,000
Free Cash Flow -14.26M
FCF Per Share -$0.18
Full Cash Flow Statement

Margins

Gross Margin 35.92%
Operating Margin -569.07%
Pretax Margin -559.02%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IceCure Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -19.84%
Shareholder Yield -19.84%
Earnings Yield -20.10%
FCF Yield -18.40%

Analyst Forecast

The average price target for IceCure Medical is $2.00, which is 102.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target $2.00
Price Target Difference 102.94%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 93.21%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

IceCure Medical has an Altman Z-Score of -15.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.36
Piotroski F-Score 2